World AIDS day 2021: “We’re fine with taking medicine… we just want everyone else to be cool with it.”

It's now four decades after the HIV/AIDS epidemic was first recognised medical science has brought an incredibly long way in the fight against this disease . Yet progress around the world has been very uneven, and in parts of Southern Africa, around 20% of the population is HIV positive.

We’re fine with taking medicine… we just want everyone else to be cool with it.

Sunny Sharma, Director Healthcare, UK

Today, on World AIDS Day, the Ipsos Knowledge Centre catches up with Sunny Sharma – Director Healthcare – who spearheads our work with clients leading the fight against HIV/AIDS in Southern & Eastern Africa.

Having worked at the intersection between public and private health for many years – including the last turbulent 18 months – Sunny has gained unique insights into the challenges and opportunities for People Living With HIV in the region. He shares these with us today, along with his outlook for the future.

The author(s)

More insights about Health

Related news

  • KEYS: Our World in Motion
    E mobility Events replay

    [Webinar] KEYS: Our World in Motion

    At our next KEYS webinar, we’ll be launching the inaugural Ipsos Mobility Report.
  • [Webinar] Real evidence from real experiences: Patient Centric Evidence
    Healthcare Webinar

    [Webinar] Real evidence from real experiences: Patient Centric Evidence

    Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
  • Battle For Attention - KEYS Webinar from Ipsos
    Communications Events replay

    [Webinar] KEYS: Battle For Attention

    In today’s hyper-fragmented landscape, communicating using short-form content and social media platforms is an essential part of our toolkit. But are they better suited to short-term engagement rather than long-term brand building? And what does genuinely innovative and creative advertising look like these days?